Abstract
The acute effects of intravenous (i.v.) cyclosporine A (CsA) on blood pressure and other haemodynamic parameters were examined in 8 patients with end-stage renal disease on haemodialysis (HD). The study was performed after the mid-week haemodialysis session, when the patients were on their dry body weight. Each patient received an i.v. infusion of 5 mg/kg of CsA in 120 ml of 5% dextrose in water during 2 hours. Heart rate, systolic and diastolic blood pressure (SBP, DBP) were monitored by the Holter system. An echocardiogram (M-mode 2-dimensional and Doppler sonography) was performed using an automatic device (Ultramark 6) before CsA administration, at 30, 60 and 120 minutes during CsA infusion, and at 30 minutes thereafter. SBP, DBP and calculated peripheral vascular resistance (CPVR) increased significantly in respect to basal values at 120 and 150 minutes (SBP: basal 130±21, 120 min: 136±20, 150 min: 140±18, p<0.05 and p<0.01, respectively. DBP: basal 80±9, 120 min: 86±13, 150 min: 88±13, p<0.05 and p<0.01, respectively. CPVR: basal 1000±228, 120 min: 1178±305, 150 min: 1236±270 dyne/s/cm5, p<0.01). However, systolic volume (SV) and cardiac output (CO) showed significant decreases from the basal values (SV: basal 103±29, 120 min: 85±22, 150 min: 85±17, p<0.05. CO: basal 8.2±2, 120 min: 7.3±1.1, 150 min: 7±1.2l/min, p<0.05). In conclusion, CsA infusion produces a significant elevation of blood pressure, which seems to be mediated by a direct action on peripheral vascular resistance.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Cohen, D., Loertscher, R., Rubin, R., Tilney, N., Carpenter, C., Strom, T.: Cyclosporine: A new immunosuppressive agent for organ transplantation.Ann. Intern. Med., 101, 667 (1984).
Thiel, G.: Experimental cyclosporine A nephrotoxicity. A summary of the International Workshop.Clin. Nephrol. 25, S205 (1986).
Chapman, R., Marcén, R., Arias, M., Raine, A., Dunnil, M., Morris, P.: Hypertension after renal transplantation. A comparison of cyclosporine and conventional immunosuppression.Transplantation, 43, 860 (1987).
Curtis, J., Luke, R., Jones, P., Diethelm, A.: Hypertension in cyclosporine-treated renal transplant recipients is sodium dependent.Am. J. Med., 85, 134 (1989).
Scherrer, U., Vissing, S., Morgan, B., Rollins, J., Tindall, R., Ring, S., Hanson, P., Mohanty, P., Victor, R.: Cyclosporine-induced sympathetic activation and hypertension after heart transplantation.N. Engl. J. Med., 323, 693 (1990).
Wagner, K., Albrecht, S., Neumayer, H.: Prevention of posttransplant acute tubular necrosis by the calcium antagonist diltiazem: A prospective randomized study.Am. J. Nephrol., 7, 287 (1987).
Feutren, G., Mihatsch, M., for the International Kidney Biopsy Registry of Cyclosporine in Autoimmune Diseases: Risk factors for cyclosporine-induced nephropathy in patients with autoimmune disease.N. Engl. J. Med., 326, 1645 (1992).
Sahn, D., MeMaria, A., Kisslo, J., Weyman, A., for the Committee on M-Mode Standardization of the American Society of Echocardiography: Recommendations regarding quantitation in M-mode echocardiography: Results of a survey of echocardiographic measurements.Circulation, 58, 1072 (1978).
Tresham, J., Whitworth, J., Scoggins, B., Bennet, W.: Cyclosporine-induced hypertension in sheep. The role of thromboxanes.Transplantation, 49, 144 (1990).
Weir, M., Klassen, D., Shen, S., Sullivan, D., Buddemeyer, E., Handwerger, B.: Acute effects of intravenous cyclosporine on blood pressure, in renal hemodynamics, and urine prostaglandin production of healthy humans.Transplantation, 49, 41 (1990).
Ellis, C., Fradin, M., Messana, J., Brown, M., Siegel, M., Hartley, A., Rocher, L., Wheeler, S., Hamilton, T., Parish, T., Ellis-Madu, M., Drell, E., Annesley, T., Cooper, K., Voorhees, J.: Cyclosporine for plaque-type psoriasis. Results of a multidose, double-blind trial.N. Engl. J. Med., 324, 277 (1991).
Bantle, J., Bourdeau, R., Ferris, T.: Suppression of plasma renin activity by cyclosporine.Am. J. Med., 83, 59 (1987).
Kiberd, B.: Cyclosporine-induced renal dysfunction in human renal allograft recipients.Transplantation, 48, 965 (1989).
Curtis, J., Luke, R., Dubovsky, E., Diethelm, A., Whelchel, F., Jones, P.: Cyclosporine in therapeutic doses increases renal allograft vascular resistance.Lancet, 2, 477 (1989).
Dawdson, I., Rooth, P., Fry, W., Sandoz, Z., Willms, C., Coorpender, L., Alway, C., Reish, J.: Prevention of acute cyclosporine-induced renal blood flow inhibition and improved immunosuppression with verapamil.Transplantation, 48, 575 (1989).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Navarro, J.F., Mora, C., Marcén, R. et al. Acute cardiovascular effects of intravenous cyclosporine. International Urology and Nephrology 28, 575–581 (1996). https://doi.org/10.1007/BF02550970
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02550970